Kamalam Unninayar

All filings by Kamalam Unninayar on record concern Harvard Bioscience Inc. Over a trading history stretching from 26 November 2018 to 7 March 2019, the count stands at 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 2 April 2019, reports a share grant in Harvard Bioscience Inc. Filings reach the SEC (Form 4) feed a median of 14 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.